Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen and currently employs 177,356 full-time employees. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.
Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Hasılat
22,678
22,873
21,833
21,067
21,532
37,520
Hasılat Artışı (YoY)
4%
5%
4%
-2%
-43%
3%
Satınalma Maliyeti
16,995
17,180
16,455
16,096
16,129
27,209
Brüt Kâr
5,683
5,693
5,378
4,971
5,403
10,311
Satış, Genel ve İdari
2,878
2,883
2,919
3,027
3,094
5,453
Araştırma ve Geliştirme
599
633
600
572
593
762
İşletme Giderleri
3,378
3,383
3,596
3,735
3,566
6,132
Diğer Finansman Gelirleri (Giderleri)
9
9
--
--
--
--
Kâr Öncesi Gelir
2,182
2,188
1,388
773
1,597
3,652
Kira Vergisi Gideri
579
582
521
485
375
833
Net Kâr
1,264
1,264
471
-594
1,372
1,818
Net Income Growth
Kâr Artışı
168%
168%
-179%
-143%
-25%
7%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
573.01
564.28
563.23
563.23
561.26
558.15
Hisse Değişimi (Yıllık Üst Üste)
2%
0%
0%
0%
1%
0%
EPS (Diluted)
2.2
2.24
0.83
-1.05
2.44
3.25
EPS Artışı
165%
170%
-179%
-143%
-25%
6%
Öz sermaye akışı
--
--
1,492
3,286
2,281
3,031
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
25.05%
24.88%
24.63%
23.59%
25.09%
27.48%
Faaliyet Kâr Marjı
10.16%
10.09%
8.16%
5.86%
8.53%
11.13%
Kâr Marjı
5.57%
5.52%
2.15%
-2.81%
6.37%
4.84%
Özsermaye Karlılık Oranı
--
--
6.83%
15.59%
10.59%
8.07%
EBITDA
--
--
1,823
1,272
1,858
4,201
EBITDA Marjinali
--
--
8.34%
6.03%
8.62%
11.19%
D&A EBITDA için
--
--
41
36
21
22
Faaliyet Kârı
2,305
2,310
1,782
1,236
1,837
4,179
Faaliyet Kâr Marjı
10.16%
10.09%
8.16%
5.86%
8.53%
11.13%
Verilen Vergi Oranı
26.53%
26.59%
37.53%
62.74%
23.48%
22.8%
Follow-Up Questions
Quels sont les états financiers clés de Fresenius SE & Co. KGaA ?
Selon le dernier état financier (Form-10K), Fresenius SE & Co. KGaA a un total d'actifs de $0, un bénéfice net kâr de $1,264
Quels sont les ratios financiers clés pour FSNUF ?
Le ratio de liquidité de Fresenius SE & Co. KGaA est 0, la marge nette est 5.52, les ventes par action sont de $40.53.
Comment les revenus de Fresenius SE & Co. KGaA sont-ils répartis par segment ou géographie ?
Fresenius SE & Co. KGaA en büyük gelir kaynağı Fresenius Kabi olup, en son kar bildiriminde geliri 8,612,000,000 dir. Coğrafi olarak, North America , Fresenius SE & Co. KGaA için ana pazar olup, geliri 2,701,000,000 dir.
Fresenius SE & Co. KGaA est-elle rentable ?
evet, selon les derniers états financiers, Fresenius SE & Co. KGaA a un bénéfice net kâr de $1,264
Fresenius SE & Co. KGaA a-t-elle des passifs ?
hayır, Fresenius SE & Co. KGaA a un passif de 0
Combien d'actions en circulation Fresenius SE & Co. KGaA a-t-elle ?
Fresenius SE & Co. KGaA a un total d'actions en circulation de 0